FLT: Measuring Tumor Cell Proliferation In Vivo With Positron Emission Tomography and 3′-Deoxy-3′-[18F]Fluorothymidine
- 1 November 2007
- journal article
- review article
- Published by Elsevier in Seminars in Nuclear Medicine
- Vol. 37 (6) , 429-439
- https://doi.org/10.1053/j.semnuclmed.2007.08.001
Abstract
No abstract availableKeywords
This publication has 64 references indexed in Scilit:
- Toxicology evaluation of radiotracer doses of 3'-deoxy-3'-[18F]fluorothymidine (18F-FLT) for human PET imaging: Laboratory analysis of serial blood samples and comparison to previously investigated therapeutic FLT dosesBMC Nuclear Medicine, 2007
- Molecular Imaging of Proliferation in Malignant LymphomaCancer Research, 2006
- Positron emission tomography in patients with breast cancer using 18F-3′-deoxy-3′-fluoro-l-thymidine (18F-FLT)—a pilot studyEuropean Journal of Surgical Oncology, 2006
- Acquisition of resistance to antitumor alkylating agent ACNU: a possible target of positron emission tomography monitoringNuclear Medicine and Biology, 2006
- True tracers: comparing FDG with glucose and FLT with thymidineNuclear Medicine and Biology, 2005
- Prognostic value of proliferation in invasive breast cancer: a reviewJournal of Clinical Pathology, 2004
- Radiosynthesis of 3′-deoxy-3′-[18F]fluorothymidine: [18F]FLT for imaging of cellular proliferation in vivoNuclear Medicine and Biology, 2000
- Fluorine-18 deoxyglucose and false-positive results: a major problem in the diagnostics of oncological patientsEuropean Journal of Nuclear Medicine and Molecular Imaging, 1996
- Overexpression of Thymidine Kinase mRNA Eliminates Cell Cycle Regulation of Thymidine Kinase Enzyme ActivityJournal of Biological Chemistry, 1996
- Graphical Evaluation of Blood-to-Brain Transfer Constants from Multiple-Time Uptake Data. GeneralizationsJournal of Cerebral Blood Flow & Metabolism, 1985